BlackRock Fund Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $13.4M | Buy |
1,019,962
+141,735
| +16% | +$1.86M | ﹤0.01% | 2411 |
|
2016
Q3 | $15.1M | Buy |
878,227
+50,875
| +6% | +$877K | ﹤0.01% | 2222 |
|
2016
Q2 | $14.9M | Buy |
827,352
+70,177
| +9% | +$1.27M | ﹤0.01% | 2188 |
|
2016
Q1 | $14.4M | Sell |
757,175
-36,101
| -5% | -$686K | ﹤0.01% | 2168 |
|
2015
Q4 | $21.2M | Buy |
793,276
+36,939
| +5% | +$986K | ﹤0.01% | 2007 |
|
2015
Q3 | $18.5M | Buy |
756,337
+113,106
| +18% | +$2.76M | ﹤0.01% | 2041 |
|
2015
Q2 | $20M | Sell |
643,231
-4,720
| -0.7% | -$147K | ﹤0.01% | 2118 |
|
2015
Q1 | $9.43M | Buy |
647,951
+7,134
| +1% | +$104K | ﹤0.01% | 2476 |
|
2014
Q4 | $6.45M | Buy |
640,817
+99,151
| +18% | +$998K | ﹤0.01% | 2719 |
|
2014
Q3 | $4.51M | Buy |
541,666
+63,395
| +13% | +$528K | ﹤0.01% | 2812 |
|
2014
Q2 | $5.89M | Buy |
+478,271
| New | +$5.89M | ﹤0.01% | 2744 |
|